Patients with Cancer Like Jobs Gain Months from New Therapies

January 28, 2011

Pfizer Inc. and Novartis AG drugs have helped patients with the same cancer as Apple Inc.’s Steve Jobs live longer in recent studies and Stanford University, near Apple’s home base, is testing new drug combinations.

The Apple chief executive officer took a leave of absence in 2004 after saying he had a neuroendocrine tumor, a malignancy that strikes about 3,000 Americans a year. He left in 2009 for a liver transplant, sometimes done when the cancer spreads...

Other researchers have also studied the success of liver transplants as a treatment for neuroendocrine tumors. In 2005, David Metz, associate chief of gastroenterology at the University of Pennsylvania in Philadelphia, published an analysis in the World Journal of Gastroenterology that suggested 60 percent or fewer of patients who underwent transplants for this purpose survive an average of 5 years... Read More